Menu

Blog

Jan 13, 2016

Could this common painkiller become a future cancer-killer?

Posted by in categories: biotech/medical, futurism

Cancer cells (credit: iStock)

Diclofenac, a common painkiller, has significant anti-cancer properties, researchers from the Repurposing Drugs in Oncology (ReDO) project have found.

ReDO, an international collaboration between the Belgium-based Anticancer Fund and the U.S.- based GlobalCures, has published their investigation into diclofenac in the open-access journal ecancermedicalscience.

Read more

Comments are closed.